Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m) convertedTranchesRegionDate
HYC
HLTH
PRCD
AVTR
Avantor Funding Inc$2,000
2USOA
Jul 7, 2020
currency
USD
size (m)
1,550.000
maturity
Jul 15, 2028
type
Fixed
tenor
8.000
call
3
registration
144A/Reg S
benchmark
-
ranking
-
moody's
B3
s&p
B-
fitch
BB
size description
-
re-open/tap
No
ipt
5.00%-5.25%
ipt-pxd
-
guidance
4.75%-5.00%
spread
407
coupon
4.625%
spread set
-
price
100.00000
yield
4.625%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, CTI, GSC, ...
joint leads
-
passive leads
-
co-managers
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, CTI, GSC, ...
joint leads
-
passive leads
-
co-managers
coordinating managers
-
currency
EUR
size (m)
400.000
maturity
Jul 15, 2028
type
Fixed
tenor
8.000
call
3
registration
144A/Reg S
benchmark
-
ranking
-
moody's
B3
s&p
B-
fitch
BB
size description
-
re-open/tap
No
ipt
4.00%-4.25%
ipt-pxd
-
guidance
4% area
spread
443
coupon
3.875%
spread set
-
price
100.00000
yield
3.875%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, CTI, GSC, ...
joint leads
-
passive leads
-
co-managers
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
BAM, BRC, CTI, GSC, ...
joint leads
-
passive leads
-
co-managers
coordinating managers
-
Tranche Comments
Registration: 144A/Reg S; Comments: 07/07/2020 Avantor Funding Inc (AVTR) approx USD2bn (up from USD1.452bn) 144A/Reg S sr notes 2-part. B3/B-/BB (positive/positive/stable). Via GS/Citi/Barc/JPM/BofA joint books, PNC, HSBC, Evercore (US$ tranche only), Jefferies as co-managers. No reg rights. Settles 07/17 (T+8). - USD1.550bn (up from USD1bn) due 07/15/28 (8y). NC3 (MWC T+50bp), then at 102.313, 101.156, 100. Equity claw: 3y 40% at 104.625. 144A CUSIP: 05352TAA7. IPT: 5.00%-5.25%. Px talk: 4.75%-5.00%. Launched: $1.55bn at 4.625%. Priced: 4.625% at 100. +407bp vs 2.875% 08/15/28. - EUR400m due 07/15/28 (8y). NC3 (MWC B+50bp), then at 101.938, 100.969, 100. Equity claw: 3y 40% at 103.875. IPT 4.00%-4.25%. Px talk: 4% area. Launched: EUR400m at 3.875%. Priced: 3.875% at 100. +443bp vs DBR 0.25% 08/15/28. Did investor call at 2pm UKT, 9am NYT 07/07. Books closed at 12pm NYT/5pm UKT 07/07. Reconfirms were due at 1pm NYT/ 6pm UKT 07/07. UOP: along with $140m cash on hand to redeem all (up from USD1.452bn portion) of its USD2bn 9% sr notes due 10/01/25 (MWC T+50bp), USD550m upsize UOP: to redeem all its 9% sr sr notes. Also increasing and extending its revolver from $250m due Nov 2022 to $515m due July 2025. Biz: a global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, HQ: Radnor, PA.; Registration: 144A/Reg S; Comments: 07/07/2020 Avantor Funding Inc (AVTR) approx USD2bn (up from USD1.452bn) 144A/Reg S sr notes 2-part. B3/B-/BB (positive/positive/stable). Via GS/Citi/Barc/JPM/BofA joint books, PNC, HSBC, Evercore (US$ tranche only), Jefferies as co-managers. No reg rights. Settles 07/17 (T+8). - USD1.550bn (up from USD1bn) due 07/15/28 (8y). NC3 (MWC T+50bp), then at 102.313, 101.156, 100. Equity claw: 3y 40% at 104.625. 144A CUSIP: 05352TAA7. IPT: 5.00%-5.25%. Px talk: 4.75%-5.00%. Launched: $1.55bn at 4.625%. Priced: 4.625% at 100. +407bp vs 2.875% 08/15/28. - EUR400m due 07/15/28 (8y). NC3 (MWC B+50bp), then at 101.938, 100.969, 100. Equity claw: 3y 40% at 103.875. IPT 4.00%-4.25%. Px talk: 4% area. Launched: EUR400m at 3.875%. Priced: 3.875% at 100. +443bp vs DBR 0.25% 08/15/28. Did investor call at 2pm UKT, 9am NYT 07/07. Books closed at 12pm NYT/5pm UKT 07/07. Reconfirms were due at 1pm NYT/ 6pm UKT 07/07. UOP: along with $140m cash on hand to redeem all (up from USD1.452bn portion) of its USD2bn 9% sr notes due 10/01/25 (MWC T+50bp), USD550m upsize UOP: to redeem all its 9% sr sr notes. Also increasing and extending its revolver from $250m due Nov 2022 to $515m due July 2025. Biz: a global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, HQ: Radnor, PA.;

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.